查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球血流動力學監測市場 - 產業趨勢與預測（~2031）
市場調查報告書
商品編碼
1398944

全球血流動力學監測市場 - 產業趨勢與預測（~2031）

Global Hemodynamic Monitoring Market - Industry Trends and Forecast to 2031
出版日期: | 出版商: Data Bridge Market Research | 英文 678 Pages | 商品交期: 請詢問到貨日

價格

全球血流動力學監測市場規模預計到 2023 年將達到 2,214,354,710 美元，到 2031 年將達到 3,839,125,070 美元，2024-2031 年預測期間複合年增長率為 7.2%。

本報告針對全球血流動力學監測市場進行研究和分析，提供產業趨勢和預測、驅動因素和限制因素、公司趨勢等資訊。

目錄

第 1 章 簡介

第二章 市場區隔

第三章執行摘要

第 4 章重要注意事項

  • PESTEL模型
  • 波特五力分析模型

第五章 全球血流動力學監測市場、監管框架

  • 美國法規
  • 歐洲法規
  • 中國法規
  • 日本法規
  • 南非法規

第六章市場概況

  • 促進者
    • 心血管疾病發生率增加
    • 手術和重症監護病房 (ICU) 入院人數增加
    • 提高遠端血流動力學監測率
    • 血流動力學監測裝置技術進展
  • 抑制因素
    • 血流動力學監測系統成本高
    • 血流動力學監測系統缺乏標準化和互通性
  • 機會
    • 整合血流動力學監測和遠距醫療
    • 擴大在各種臨床環境中的使用
  • 任務
    • 與血流動力學監測相關的資料安全和隱私問題
    • 解釋和實現的複雜性

第七章全球血流動力學監測市場：按產品

  • 概述
  • 血流動力學監測系統
    • 按類型
  • 生命體徵監護儀
    • 按方式
    • 按類型
    • 按配置
    • 按專利類型
  • 脈搏血氧儀
    • 手提脈搏血氧儀
    • 桌上型脈搏血氧儀
  • 導管
    • 肺動脈導管
    • 動脈導管
    • 中心靜脈導管
    • 其他
  • 耗材及配件
    • 壓力感測器
    • 電極、感測器
    • 探測
    • 電纜、連接器
    • 其他

第八章全球血流動力學監測市場：按類型

  • 概述
  • 非侵入性血流動力學監測
  • 微創血流動力學監測
  • 有創血流動力學監測

第九章全球血流動力學監測市場：依方式分類

  • 概述
  • 獨立的
  • 桌面
  • 便攜的
  • 可穿戴
  • 其他

第十章全球血流動力學監測市場：依應用分類

  • 概述
  • 醫院監測
  • 基於實驗室的監測
  • 家庭監控

第十一章全球血流動力學監測市場：按構成

  • 概述
  • 自動的
  • 手動的

第十二章全球血流動力學監測市場：依年齡組

  • 概述
  • 成人
  • 老年人
  • 孩子

第十三章全球血流動力學監測市場：依最終用戶分類

  • 概述
  • 醫院
    • 私立
    • 公共
  • 門診手術中心
  • 導管治療室
  • 療養院
  • 居家護理
  • 醫療機構
    • 私立
    • 公共
  • 康復中心
  • 其他

第14章全球血流動力學監測市場：依通路劃分

  • 概述
  • 離線
    • 直接報價
    • 藥店
    • 超市/超市
  • 在線的
    • 電子商務
    • 企業網站

第十五章全球血流動力學監測市場：按地區

  • 概述
  • 北美
    • 美國
    • 加拿大
    • 墨西哥

The global hemodynamic monitoring market is expected to reach USD 3,839,125.07 thousand by 2031 from USD 2,214,354.71 thousand in 2023, growing at a CAGR of 7.2% during the forecast period of 2024 to 2031.

Market Segmentation

Global Hemodynamic Monitoring Market, Product (Hemodynamic Monitoring Systems, Vital Sign Monitors, Pulse Oximeters, Catheters and Consumables and Accessories), Type (Non-Invasive Hemodynamic Monitoring, Minimally Invasive Hemodynamic Monitoring and Invasive Hemodynamic Monitoring), Modality (Standalone, Table Top, Portable, Wearable and Other), Application (Hospitals-Based Monitoring, Laboratory-Based Monitoring and Home-Based Monitoring), Configuration (Automated and Manual), Age Group (Adult, Geriatric and Pediatric), End User (Hospitals, Ambulatory Surgical Centers, Catheterization Labs, Nursing Homes, Homecare, Medical Institutions, Rehabilitation Centers and Others) Distribution Channel (Offline and Online), Country (U.S., Canada, Mexico, Germany, U.K., France, Russia, Italy, Spain, Turkey, Poland, Belgium, Netherlands, Switzerland, Denmark, Sweden, Norway, Finland, Rest of Europe, China, Japan, India, Australia, South Korea, New Zealand, Singapore, Thailand, Philippines, Malaysia, Indonesia, Vietnam, Taiwan, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, Saudi Arabia, UAE, South Africa, Egypt, Qatar, Kuwait, Oman, Bahrain and Rest of Middle East And Africa) - Industry Trends and Forecast to 2031.

Overview of Global Hemodynamic Monitoring Market Dynamics

  • Driver
  • Rising incidence of cardiovascular disorders
  • Restraint
  • High cost of hemodynamic monitoring systems
  • Opportunity
  • Integration of hemodynamic monitoring with telemedicine

Market Players

Some of the major market players operating in the global hemodynamic monitoring market are listed below:

  • Icumedical
  • Teleflex Incorporated
  • Koninklijke Philips N.V.
  • GE HealthCare
  • Edwards Lifesciences Corporation
  • Masimo
  • Baxter
  • Getinge AB
  • CONTEC MEDICAL SYSTEMS CO.,LTD
  • Nihon Kohden Corporation
  • Merit Medical Systems
  • Dragerwerk AG & Co. KGaA
  • OSYPKA MEDICAL
  • Deltex Medical, SC
  • Schwarzer Cardiotek
  • Caretaker, LLC.
  • Uscom
  • NI-Medical
  • CNSystems Medizintechnik GmbH
  • Argon Medical Devices

TABLE OF CONTENTS

1 INTRODUCTION 81

  • 1.1 OBJECTIVES OF THE STUDY 81
  • 1.2 MARKET DEFINITION 81
  • 1.3 OVERVIEW OF THE GLOBAL HEMODYNAMIC MONITORING MARKET 81
  • 1.4 LIMITATIONS 83
  • 1.5 MARKETS COVERED 83

2 MARKET SEGMENTATION 88

  • 2.1 MARKETS COVERED 88
  • 2.2 GEOGRAPHICAL SCOPE 89
  • 2.3 YEARS CONSIDERED FOR THE STUDY 90
  • 2.4 CURRENCY AND PRICING 90
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL 91
  • 2.6 MULTIVARIATE MODELLING 94
  • 2.7 TREATMENT LIFELINE CURVE 94
  • 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 95
  • 2.9 DBMR MARKET POSITION GRID 96
  • 2.10 MARKET APPLICATION COVERAGE GRID 97
  • 2.11 VENDOR SHARE ANALYSIS 98
  • 2.12 SECONDARY SOURCES 99
  • 2.13 ASSUMPTIONS 99

3 EXECUTIVE SUMMARY 100

4 PREMIUM INSIGHTS 106

  • 4.1 PESTEL'S MODEL 106
  • 4.2 PORTER'S FIVE FORCES MODEL 107

5 GLOBAL HEMODYNAMIC MONITORING MARKET, REGULATORY FRAMEWORK 108

  • 5.1 REGULATION IN U.S 108
  • 5.2 REGULATION IN EUROPE 110
  • 5.3 REGULATION IN CHINA 111
  • 5.4 REGULATION IN JAPAN 111
  • 5.5 REGULATION IN SOUTH AFRICA 112

 

6 MARKET OVERVIEW 113

  • 6.1 DRIVERS 115
    • 6.1.1 RISING INCIDENCE OF CARDIOVASCULAR DISORDERS 115
    • 6.1.2 INCREASING SURGICAL PROCEDURES AND INTENSIVE CARE UNIT (ICU) ADMISSIONS 116
    • 6.1.3 INCREASING REMOTE HEMODYNAMIC MONITORING RATES 117
    • 6.1.4 TECHNOLOGICAL ADVANCEMENTS IN HEMODYNAMIC MONITORING DEVICES 118
  • 6.2 RESTRAINTS 119
    • 6.2.1 HIGH COST OF HEMODYNAMIC MONITORING SYSTEMS 119
    • 6.2.2 LACK OF STANDARDIZATION AND INTEROPERABILITY IN HEMODYNAMIC MONITORING SYSTEMS 119
  • 6.3 OPPORTUNITIES 120
    • 6.3.1 INTEGRATION OF HEMODYNAMIC MONITORING WITH TELEMEDICINE 120
    • 6.3.2 EXPANDING APPLICATIONS IN DIFFERENT CLINICAL SETTINGS 121
  • 6.4 CHALLENGES 123
    • 6.4.1 DATA SECURITY AND PRIVACY CONCERNS ASSOCIATED WITH HEMODYNAMIC MONITORING 123
    • 6.4.2 COMPLEXITY IN INTERPRETATION AND IMPLEMENTATION 123

7 GLOBAL HEMODYNAMIC MONITORING MARKET, BY PRODUCT 125

  • 7.1 OVERVIEW 126
  • 7.2 HEMODYNAMIC MONITORING SYSTEMS 129
    • 7.2.1 BY TYPE 130
      • 7.2.1.1 NON-INVASIVE HEMODYNAMIC MONITORING SYSTEMS 130
      • 7.2.1.2 INVASIVE HEMODYNAMIC MONITORING SYSTEMS 130
  • 7.3 VITAL SIGN MONITORS 130
    • 7.3.1 BY MODALITY 131
      • 7.3.1.1 BEDSIDE MONITORS 131
      • 7.3.1.2 TABLETOP MONITORS 131
      • 7.3.1.3 PORTABLE/COMPACT MONITORS 131
      • 7.3.1.4 WEARABLE MONITORS 131
    • 7.3.2 BY TYPE 132
      • 7.3.2.1 DIGITAL MONITORS 132
      • 7.3.2.2 TRADITIONAL ANALOG MONITORS 132
    • 7.3.3 BY CONFIGURATION 132
      • 7.3.3.1 AUTOMATED 132
      • 7.3.3.2 MANUAL 132
    • 7.3.4 BY PATEINT TYPE 133
      • 7.3.4.1 ADULT 133
      • 7.3.4.2 GERIATRIC 133
      • 7.3.4.3 PEDIATRIC 133

 

  • 7.4 PULSE OXIMETERS 134
    • 7.4.1 PORTABLE PULSE OXIMETERS 134
      • 7.4.1.1 BY TYPE 135
        • 7.4.1.1.1 FINGERTIP PULSE OXIMETERS 135
        • 7.4.1.1.2 HANDHELD PULSE OXIMETERS 135
        • 7.4.1.1.3 WEARABLE PULSE OXIMETERS 135
        • 7.4.1.1.4 OTHER 135
      • 7.4.1.2 BY TECHNOLOGY 136
        • 7.4.1.2.1 CONVENTIONAL DEVICES 136
        • 7.4.1.2.2 CONNECTED DEVICES 136
    • 7.4.2 TABLE TOP PULSE OXIMETERS 136
  • 7.5 CATHETERS 137
    • 7.5.1 PULMONARY ARTERY CATHETERS 137
    • 7.5.2 ARTERIAL CATHETERS 137
    • 7.5.3 CENTRAL VENOUS CATHETERS 138
    • 7.5.4 OTHERS 138
  • 7.6 CONSUMABLES AND ACCESSORIES 138
    • 7.6.1 PRESSURE TRANSDUCERS 139
    • 7.6.2 ELECTRODES AND SENSORS 139
    • 7.6.3 PROBES 139
    • 7.6.4 CABLES AND CONNECTORS 139
    • 7.6.5 OTHERS 139

8 GLOBAL HEMODYNAMIC MONITORING MARKET, BY TYPE 140

  • 8.1 OVERVIEW 141
  • 8.2 NON-INVASIVE HEMODYNAMIC MONITORING 144
  • 8.3 MINIMALLY INVASIVE HEMODYNAMIC MONITORING 145
  • 8.4 INVASIVE HEMODYNAMIC MONITORING 145

9 GLOBAL HEMODYNAMIC MONITORING MARKET, BY MODALITY 146

  • 9.1 OVERVIEW 147
  • 9.2 STANDALONE 150
  • 9.3 TABLE TOP 151
  • 9.4 PORTABLE 151
  • 9.5 WEARABLE 152
  • 9.6 OTHER 152

 

10 GLOBAL HEMODYNAMIC MONITORING MARKET, BY APPLICATION 153

  • 10.1 OVERVIEW 154
  • 10.2 HOSPITALS-BASED MONITORING 157
    • 10.2.1 HEMODYNAMIC MONITORING SYSTEMS 158
    • 10.2.2 VITAL SIGN MONITORS 158
    • 10.2.3 PULSE OXIMETERS 158
    • 10.2.4 CATHETERS 158
    • 10.2.5 CONSUMABLES AND ACCESSORIES 158
  • 10.3 LABORATORY-BASED MONITORING 159
    • 10.3.1 VITAL SIGN MONITORS 159
    • 10.3.2 PULSE OXIMETERS 159
    • 10.3.3 HEMODYNAMIC MONITORING SYSTEMS 160
    • 10.3.4 CATHETERS 160
    • 10.3.5 CONSUMABLES AND ACCESSORIES 160
  • 10.4 HOME-BASED MONITORING 160
    • 10.4.1 PULSE OXIMETERS 161
    • 10.4.2 VITAL SIGN MONITORS 161
    • 10.4.3 HEMODYNAMIC MONITORING SYSTEMS 161
    • 10.4.4 CATHETERS 161
    • 10.4.5 CONSUMABLES AND ACCESSORIES 161

11 GLOBAL HEMODYNAMIC MONITORING MARKET, BY CONFIGURATION 162

  • 11.1 OVERVIEW 163
  • 11.2 AUTOMATED 166
  • 11.3 MANUAL 166

12 GLOBAL HEMODYNAMIC MONITORING MARKET, BY AGE GROUP 167

  • 12.1 OVERVIEW 168
  • 12.2 ADULT 171
  • 12.3 GERIATRIC 172
  • 12.4 PEDIATRIC 172

13 GLOBAL HEMODYNAMIC MONITORING MARKET, BY END USER 173

  • 13.1 OVERVIEW 174
  • 13.2 HOSPITALS 177
    • 13.2.1 PRIVATE 178
      • 13.2.1.1 TIER 1 178
      • 13.2.1.2 TIER 2 178
      • 13.2.1.3 TIER 3 179

 

    • 13.2.2 PUBLIC 179
      • 13.2.2.1 TIER 1 179
      • 13.2.2.2 TIER 2 179
      • 13.2.2.3 TIER 3 179
  • 13.3 AMBULATORY SURGICAL CENTERS 180
  • 13.4 CATHETERIZATION LABS 180
  • 13.5 NURSING HOMES 181
  • 13.6 HOMECARE 181
  • 13.7 MEDICAL INSTITUTIONS 182
    • 13.7.1 PRIVATE 182
    • 13.7.2 PUBLIC 182
  • 13.8 REHABILITATION CENTERS 183
  • 13.9 OTHERS 183

14 GLOBAL HEMODYNAMIC MONITORING MARKET, BY DISTRIBUTION CHANNEL 184

  • 14.1 OVERVIEW 185
  • 14.2 OFFLINE 188
    • 14.2.1 DIRECT TENDERS 189
    • 14.2.2 PHARMACIES 189
      • 14.2.2.1 RETAIL PHARMACIES 189
      • 14.2.2.2 HOSPITALS PHARMACIES 190
      • 14.2.2.3 OTHERS 190
    • 14.2.3 HYPERMARKETS/SUPERMARKETS 190
  • 14.3 ONLINE 190
    • 14.3.1 E-COMMERCE 191
    • 14.3.2 COMPANY WEBSITES 191

15 GLOBAL HEMODYNAMIC MONITORING MARKET, BY REGION 192

  • 15.1 OVERVIEW 193
  • 15.2 NORTH AMERICA 197
    • 15.2.1 U.S. 207
    • 15.2.2 CANADA 216
    • 15.2.3 MEXICO 225
  • 15.3 EUROPE 234
    • 15.3.1 GERMANY 244
    • 15.3.2 FRANCE 253
    • 15.3.3 ITALY 262
    • 15.3.4 SPAIN 271
    • 15.3.5 U.K. 280
    • 15.3.6 SWITZERLAND 289
    • 15.3.7 NETHERLANDS 298
    • 15.3.8 RUSSIA 307
    • 15.3.9 TURKEY 316
    • 15.3.10 POLAND 325
    • 15.3.11 SWEDEN 334
    • 15.3.12 BELGIUM 343
    • 15.3.13 DENMARK 352
    • 15.3.14 FINALAND 361
    • 15.3.15 NORWAY 370
    • 15.3.16 REST OF EUROPE 379
  • 15.4 ASIA-PACIFIC 380
    • 15.4.1 CHINA 390
    • 15.4.2 JAPAN 399
    • 15.4.3 INDIA 408
    • 15.4.4 SOUTH KOREA 417
    • 15.4.5 AUSTRALIA 426
    • 15.4.6 SINGAPORE 435
    • 15.4.7 THAILAND 444
    • 15.4.8 INDONESIA 453
    • 15.4.9 PHILIPPINES 462
    • 15.4.10 MALAYSIA 471
    • 15.4.11 NEW ZEALAND 480
    • 15.4.12 VIETNAM 489
    • 15.4.13 TAIWAN 498
    • 15.4.14 REST OF ASIA-PACIFIC 507

 

  • 15.5 MIDDLE EAST AND AFRICA 508
    • 15.5.1 SAUDI ARABIA 518
    • 15.5.2 SOUTH AFRICA 527
    • 15.5.3 U.A.E. 536
    • 15.5.4 EGYPT 545
    • 15.5.5 QATAR 554
    • 15.5.6 ISRAEL 563
    • 15.5.7 OMAN 572
    • 15.5.8 BAHRAIN 581
    • 15.5.9 REST OF MIDDLE EAST AND AFRICA 590
  • 15.6 SOUTH AMERICA 591
    • 15.6.1 BRAZIL 601
    • 15.6.2 ARGENTINA 610
    • 15.6.3 REST OF SOUTH AMERICA 619

16 GLOBAL HEMODYNAMIC MONITORING MARKET, COMPANY LANDSCAPE 620

    • 16.1.1 COMPANY SHARE ANALYSIS: GLOBAL 620

17 NORTH AMERICA HEMODYNAMIC MONITORING MARKET, COMPANY LANDSCAPE 621

  • 17.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 621

18 EUROPE HEMODYNAMIC MONITORING MARKET, COMPANY LANDSCAPE 622

  • 18.1 COMPANY SHARE ANALYSIS: EUROPE 622

19 ASIA-PACIFIC HEMODYNAMIC MONITORING MARKET, COMPANY 623

  • 19.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 623

20 SWOT ANALYSIS 624

21 COMPANY PROFILES 625

  • 21.1 EDWARDS LIFESCIENCES CORPORATION 625
    • 21.1.1 COMPANY SNAPSHOT 625
    • 21.1.2 REVENUE ANALYSIS 626
    • 21.1.3 COMPANY SHARE ANALYSIS 626
    • 21.1.4 PRODUCT PORTFOLIO 627
    • 21.1.5 RECENT DEVELOPMENT 628
  • 21.2 MASIMO 629
    • 21.2.1 COMPANY SNAPSHOT 629
    • 21.2.2 REVENUE ANALYSIS 629
    • 21.2.3 COMPANY SHARE ANALYSIS 630
    • 21.2.4 PRODUCT PORTFOLIO 630
    • 21.2.5 RECENT DEVELOPMENT 631
  • 21.3 GETINGE AB 632
    • 21.3.1 COMPANY SNAPSHOT 632
    • 21.3.2 REVENUE ANALYSIS 632
    • 21.3.3 COMPANY SHARE ANALYSIS 633
    • 21.3.4 PRODUCT PORTFOLIO 633
    • 21.3.5 RECENT DEVELOPMENT 633
  • 21.4 BAXTER 634
    • 21.4.1 COMPANY SNAPSHOT 634
    • 21.4.2 REVENUE ANALYSIS 634
    • 21.4.3 COMPANY SHARE ANALYSIS 635
    • 21.4.4 PRODUCT PORTFOLIO 635
    • 21.4.5 RECENT DEVELOPMENT 635
  • 21.5 TELEFLEX INCORPORATED 637
    • 21.5.1 COMPANY SNAPSHOT 637
    • 21.5.2 REVENUE ANALYSIS 637
    • 21.5.3 COMPANY SHARE ANALYSIS 638
    • 21.5.4 PRODUCT PORTFOLIO 638
    • 21.5.5 RECENT DEVELOPMENT 639
  • 21.6 ARGON MEDICAL DEVICES 640
    • 21.6.1 COMPANY SNAPSHOT 640
    • 21.6.2 PRODUCT PORTFOLIO 641
    • 21.6.3 RECENT DEVELOPMENT 641
  • 21.7 CARETAKER, LLC. 642
    • 21.7.1 COMPANY SNAPSHOT 642
    • 21.7.2 PRODUCT PORTFOLIO 642
    • 21.7.3 RECENT DEVELOPMENT 643
  • 21.8 CNSYSTEMS MEDIZINTECHNIK GMBH 644
    • 21.8.1 COMPANY SNAPSHOT 644
    • 21.8.2 PRODUCT PORTFOLIO 644
    • 21.8.3 RECENT DEVELOPMENT 645
  • 21.9 CONTEC MEDICAL SYSTEMS CO.,LTD 646
    • 21.9.1 COMPANY SNAPSHOT 646
    • 21.9.2 REVENUE ANALYSIS 646
    • 21.9.3 PRODUCT PORTFOLIO 647
    • 21.9.4 RECENT DEVELOPMENT 649
  • 21.10 DELTEX MEDICAL, SC 650
    • 21.10.1 COMPANY SNAPSHOT 650
    • 21.10.2 PRODUCT PORTFOLIO 650
    • 21.10.3 RECENT DEVELOPMENT 651
  • 21.11 DRAGERWERK AG & CO. KGAA 652
    • 21.11.1 COMPANY SNAPSHOT 652
    • 21.11.2 REVENUE ANALYSIS 652
    • 21.11.3 PRODUCT PORTFOLIO 653
    • 21.11.4 RECENT DEVELOPMENT 653
  • 21.12 GE HEALTHCARE 654
    • 21.12.1 COMPANY SNAPSHOT 654
    • 21.12.2 REVENUE ANALYSIS 654
    • 21.12.3 PRODUCT PORTFOLIO 655
    • 21.12.4 RECENT DEVELOPMENT 656
  • 21.13 ICUMEDICAL 657
    • 21.13.1 COMPANY SNAPSHOT 657
    • 21.13.2 REVENUE ANALYSIS 657
    • 21.13.3 PRODUCT PORTFOLIO 658
    • 21.13.4 RECENT DEVELOPMENT 659
  • 21.14 KONINKLIJKE PHILIPS N.V. 660
    • 21.14.1 COMPANY SNAPSHOT 660
    • 21.14.2 REVENUE ANALYSIS 660
    • 21.14.3 PRODUCT PORTFOLIO 661
    • 21.14.4 RECENT DEVELOPMENT 661
  • 21.15 MERIT MEDICAL SYSTEMS 662
    • 21.15.1 COMPANY SNAPSHOT 662
    • 21.15.2 REVENUE ANALYSIS 662
    • 21.15.3 PRODUCT PORTFOLIO 663
    • 21.15.4 RECENT DEVELOPMENT 663
  • 21.16 NIHON KOHDEN CORPORATION 664
    • 21.16.1 COMPANY SNAPSHOT 664
    • 21.16.2 REVENUE ANALYSIS 664
    • 21.16.3 PRODUCT PORTFOLIO 665
    • 21.16.4 RECENT DEVELOPMENT 666
  • 21.17 NI-MEDICAL 667
    • 21.17.1 COMPANY SNAPSHOT 667
    • 21.17.2 PRODUCT PORTFOLIO 667
    • 21.17.3 RECENT DEVELOPMENT 667
  • 21.18 OSYPKA MEDICAL 668
    • 21.18.1 COMPANY SNAPSHOT 668
    • 21.18.2 PRODUCT PORTFOLIO 668
    • 21.18.3 RECENT DEVELOPMENT 669

 

  • 21.19 SCHWARZER CARDIOTEK 670
    • 21.19.1 COMPANY SNAPSHOT 670
    • 21.19.2 PRODUCT PORTFOLIO 670
    • 21.19.3 RECENT DEVELOPMENT 671
  • 21.20 USCOM 672
    • 21.20.1 COMPANY SNAPSHOT 672
    • 21.20.2 PRODUCT PORTFOLIO 672
    • 21.20.3 RECENT DEVELOPMENT 672

22 QUESTIONNAIRE 673

23 RELATED REPORTS 678

LIST OF TABLES

  • TABLE 1 GLOBAL HEMODYNAMIC MONITORING MARKET, BY PRODUCT, 2024-2031 (USD THOUSAND) 129
  • TABLE 2 GLOBAL HEMODYNAMIC MONITORING SYSTEMS IN HEMODYNAMIC MONITORING MARKET, BY REGION, 2022-2031 (USD THOUSAND) 129
  • TABLE 3 GLOBAL HEMODYNAMIC MONITORING SYSTEMS IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 130
  • TABLE 4 GLOBAL VITAL SIGN MONITORS IN HEMODYNAMIC MONITORING MARKET, BY REGION, 2022-2031 (USD THOUSAND) 130
  • TABLE 5 GLOBAL VITAL SIGN MONITORS IN HEMODYNAMIC MONITORING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 131
  • TABLE 6 GLOBAL VITAL SIGN MONITORS IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 132
  • TABLE 7 GLOBAL VITAL SIGN MONITORS IN HEMODYNAMIC MONITORING MARKET, BY CONFIGURATION, 2022-2031 (USD THOUSAND) 132
  • TABLE 8 GLOBAL VITAL SIGN MONITORS IN HEMODYNAMIC MONITORING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND) 133
  • TABLE 9 GLOBAL PULSE OXIMETERS IN HEMODYNAMIC MONITORING MARKET, BY REGION, 2022-2031 (USD THOUSAND) 134
  • TABLE 10 GLOBAL PULSE OXIMETERS IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 134
  • TABLE 11 GLOBAL PORTABLE PULSE OXIMTERS IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 135
  • TABLE 12 GLOBAL PULSE OXIMTERS IN HEMODYNAMIC MONITORING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND) 136
  • TABLE 13 GLOBAL CATHETERS IN HEMODYNAMIC MONITORING MARKET, BY REGION, 2022-2031 (USD THOUSAND) 137
  • TABLE 14 GLOBAL CATHETERS IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 137
  • TABLE 15 GLOBAL CONSUMABLES AND ACCESSORIES IN HEMODYNAMIC MONITORING MARKET, BY REGION, 2022-2031 (USD THOUSAND) 138
  • TABLE 16 GLOBAL CONSUMABLES AND ACCESSORIES IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 138
  • TABLE 17 GLOBAL HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 144
  • TABLE 18 GLOBAL NON-INVASIVE HEMODYNAMIC MONITORING IN HEMODYNAMIC MONITORING MARKET, BY REGION, 2022-2031 (USD THOUSAND) 144
  • TABLE 19 GLOBAL MINIMALLY INVASIVE HEMODYNAMIC MONITORING IN HEMODYNAMIC MONITORING MARKET, BY REGION, 2022-2031 (USD THOUSAND) 145
  • TABLE 20 GLOBAL INVASIVE HEMODYNAMIC MONITORING IN HEMODYNAMIC MONITORING MARKET, BY REGION, 2022-2031 (USD THOUSAND) 145
  • TABLE 21 GLOBAL HEMODYNAMIC MONITORING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 150
  • TABLE 22 GLOBAL STANDALONE IN HEMODYNAMIC MONITORING MARKET, BY REGION, 2022-2031 (USD THOUSAND) 150
  • TABLE 23 GLOBAL TABLE TOP IN HEMODYNAMIC MONITORING MARKET, BY REGION, 2022-2031 (USD THOUSAND) 151
  • TABLE 24 GLOBAL PORTABLE IN HEMODYNAMIC MONITORING MARKET, BY REGION, 2022-2031 (USD THOUSAND) 151
  • TABLE 25 GLOBAL WEARABLE IN HEMODYNAMIC MONITORING MARKET, BY REGION, 2022-2031 (USD THOUSAND) 152
  • TABLE 26 GLOBAL OTHER IN HEMODYNAMIC MONITORING MARKET, BY REGION, 2022-2031 (USD THOUSAND) 152
  • TABLE 27 GLOBAL HEMODYNAMIC MONITORING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 156
  • TABLE 28 GLOBAL HOSPITALS-BASED MONITORING IN HEMODYNAMIC MONITORING MARKET, BY REGION, 2022-2031 (USD THOUSAND) 157
  • TABLE 29 GLOBAL HOSPITALS-BASED MONITORING IN HEMODYNAMIC MONITORING MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND) 158
  • TABLE 30 GLOBAL LABORATORY-BASED MONITORING IN HEMODYNAMIC MONITORING MARKET, BY REGION, 2022-2031 (USD THOUSAND) 159
  • TABLE 31 GLOBAL LABORATORY-BASED MONITORING IN HEMODYNAMIC MONITORING MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND) 159
  • TABLE 32 GLOBAL HOME-BASED MONITORING IN HEMODYNAMIC MONITORING MARKET, BY REGION, 2022-2031 (USD THOUSAND) 160
  • TABLE 33 GLOBAL HOME-BASED MONITORING IN HEMODYNAMIC MONITORING MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND) 161
  • TABLE 34 GLOBAL HEMODYNAMIC MONITORING MARKET, BY CONFIGURATION, 2022-2031 (USD THOUSAND) 165
  • TABLE 35 GLOBAL AUTOMATED IN HEMODYNAMIC MONITORING MARKET, BY REGION, 2022-2031 (USD THOUSAND) 166
  • TABLE 36 GLOBAL MANUAL IN HEMODYNAMIC MONITORING MARKET, BY REGION, 2022-2031 (USD THOUSAND) 166
  • TABLE 37 GLOBAL HEMODYNAMIC MONITORING MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 171
  • TABLE 38 GLOBAL ADULT IN HEMODYNAMIC MONITORING MARKET, BY REGION, 2022-2031 (USD THOUSAND) 171
  • TABLE 39 GLOBAL GERIATRIC IN HEMODYNAMIC MONITORING MARKET, BY REGION, 2022-2031 (USD THOUSAND) 172
  • TABLE 40 GLOBAL PEDIATRIC IN HEMODYNAMIC MONITORING MARKET, BY REGION, 2022-2031 (USD THOUSAND) 172
  • TABLE 41 GLOBAL HEMODYNAMIC MONITORING MARKET, BY END USER, 2022-2031 (USD THOUSAND) 177
  • TABLE 42 GLOBAL HOSPITALS IN HEMODYNAMIC MONITORING MARKET, BY REGION, 2022-2031 (USD THOUSAND) 177
  • TABLE 43 GLOBAL HOSPITALS IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 178
  • TABLE 44 GLOBAL PRIVATE IN HEMODYNAMIC MONITORING MARKET, BY TIER, 2022-2031 (USD THOUSAND) 178
  • TABLE 45 GLOBAL PUBLIC IN HEMODYNAMIC MONITORING MARKET, BY TIER, 2022-2031 (USD THOUSAND) 179
  • TABLE 46 GLOBAL AMBULATORY SURGICAL CENTERS IN HEMODYNAMIC MONITORING MARKET, BY REGION, 2022-2031 (USD THOUSAND) 180
  • TABLE 47 GLOBAL CATHETERIZATION LABS IN HEMODYNAMIC MONITORING MARKET, BY REGION, 2022-2031 (USD THOUSAND) 180
  • TABLE 48 GLOBAL NURSING HOMES IN HEMODYNAMIC MONITORING MARKET, BY REGION, 2022-2031 (USD THOUSAND) 181
  • TABLE 49 GLOBAL HOMECARE IN HEMODYNAMIC MONITORING MARKET, BY REGION, 2022-2031 (USD THOUSAND) 181
  • TABLE 50 GLOBAL MEDICAL INSTITUTIONS IN HEMODYNAMIC MONITORING MARKET, BY REGION, 2022-2031 (USD THOUSAND) 182
  • TABLE 51 GLOBAL MEDICAL INSTITUTIONS IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 182
  • TABLE 52 GLOBAL REHABILITATION CENTERS IN HEMODYNAMIC MONITORING MARKET, BY REGION, 2022-2031 (USD THOUSAND) 183
  • TABLE 53 GLOBAL OTHERS IN HEMODYNAMIC MONITORING MARKET, BY REGION, 2022-2031 (USD THOUSAND) 183
  • TABLE 54 GLOBAL HEMODYNAMIC MONITORING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND) 187
  • TABLE 55 GLOBAL OFFLINE IN HEMODYNAMIC MONITORING MARKET, BY REGION, 2022-2031 (USD THOUSAND) 188
  • TABLE 56 GLOBAL OFFLINE IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 189
  • TABLE 57 GLOBAL PHARMACIES IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 189
  • TABLE 58 GLOBAL ONLINE IN HEMODYNAMIC MONITORING MARKET, BY REGION, 2022-2031 (USD THOUSAND) 190
  • TABLE 59 GLOBAL ONLINE IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 191
  • TABLE 60 GLOBAL HEMODYNAMIC MONITORING MARKET, BY REGION, 2022-2031 (USD THOUSAND) 196
  • TABLE 61 NORTH AMERICA HEMODYNAMIC MONITORING MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND) 197
  • TABLE 62 NORTH AMERICA HEMODYNAMIC MONITORING MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND) 197
  • TABLE 63 NORTH AMERICA HEMODYNAMIC MONITORING SYSTEMS IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 197
  • TABLE 64 NORTH AMERICA VITAL SIGN MONITORS IN HEMODYNAMIC MONITORING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 198
  • TABLE 65 NORTH AMERICA VITAL SIGN MONITORS IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 198
  • TABLE 66 NORTH AMERICA VITAL SIGN MONITORS IN HEMODYNAMIC MONITORING MARKET, BY CONFIGURATION, 2022-2031 (USD THOUSAND) 198
  • TABLE 67 NORTH AMERICA VITAL SIGN MONITORS IN HEMODYNAMIC MONITORING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND) 199
  • TABLE 68 NORTH AMERICA PULSE OXIMETERS IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 199
  • TABLE 69 NORTH AMERICA PORTABLE PULSE OXIMETERS IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 199
  • TABLE 70 NORTH AMERICA PULSE OXIMETERS IN HEMODYNAMIC MONITORING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND) 200
  • TABLE 71 NORTH AMERICA CATHETERS IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 200
  • TABLE 72 NORTH AMERICA CONSUMABLES AND ACCESSORIES IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 200
  • TABLE 73 NORTH AMERICA HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 201
  • TABLE 74 NORTH AMERICA HEMODYNAMIC MONITORING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 201
  • TABLE 75 NORTH AMERICA HEMODYNAMIC MONITORING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 201
  • TABLE 76 NORTH AMERICA HOSPITALS-BASED MONITORING IN HEMODYNAMIC MONITORING MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND) 202
  • TABLE 77 NORTH AMERICA LABORATORY-BASED MONITORING IN HEMODYNAMIC MONITORING MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND) 202
  • TABLE 78 NORTH AMERICA HOME-BASED MONITORING IN HEMODYNAMIC MONITORING MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND) 203
  • TABLE 79 NORTH AMERICA HEMODYNAMIC MONITORING MARKET, BY CONFIGURATION, 2022-2031 (USD THOUSAND) 203
  • TABLE 80 NORTH AMERICA HEMODYNAMIC MONITORING MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 203
  • TABLE 81 NORTH AMERICA HEMODYNAMIC MONITORING MARKET, BY END USER, 2022-2031 (USD THOUSAND) 204
  • TABLE 82 NORTH AMERICA HOSPITALS IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 204
  • TABLE 83 NORTH AMERICA PRIVATE IN HEMODYNAMIC MONITORING MARKET, BY TIER, 2022-2031 (USD THOUSAND) 204
  • TABLE 84 NORTH AMERICA PUBLIC IN HEMODYNAMIC MONITORING MARKET, BY TIER, 2022-2031 (USD THOUSAND) 205
  • TABLE 85 NORTH AMERICA MEDICAL INSTITUTIONS IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 205
  • TABLE 86 NORTH AMERICA HEMODYNAMIC MONITORING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND) 205
  • TABLE 87 NORTH AMERICA OFFLINE IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 205
  • TABLE 88 NORTH AMERICA PHARMACIES IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 206
  • TABLE 89 NORTH AMERICA ONLINE IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 206
  • TABLE 90 U.S. HEMODYNAMIC MONITORING MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND) 207
  • TABLE 91 U.S. HEMODYNAMIC MONITORING SYSTEMS IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 207
  • TABLE 92 U.S. VITAL SIGN MONITORS IN HEMODYNAMIC MONITORING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 207
  • TABLE 93 U.S. VITAL SIGN MONITORS IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 208
  • TABLE 94 U.S. VITAL SIGN MONITORS IN HEMODYNAMIC MONITORING MARKET, BY CONFIGURATION, 2022-2031 (USD THOUSAND) 208
  • TABLE 95 U.S. VITAL SIGN MONITORS IN HEMODYNAMIC MONITORING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND) 208
  • TABLE 96 U.S. PULSE OXIMETERS IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 208
  • TABLE 97 U.S. PORTABLE PULSE OXIMETERS IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 209
  • TABLE 98 U.S. PULSE OXIMETERS IN HEMODYNAMIC MONITORING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND) 209
  • TABLE 99 U.S. CATHETERS IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 209
  • TABLE 100 U.S. CONSUMABLES AND ACCESSORIES IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 210
  • TABLE 101 U.S. HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 210
  • TABLE 102 U.S. HEMODYNAMIC MONITORING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 210
  • TABLE 103 U.S. HEMODYNAMIC MONITORING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 211
  • TABLE 104 U.S. HOSPITALS-BASED MONITORING IN HEMODYNAMIC MONITORING MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND) 211
  • TABLE 105 U.S. LABORATORY-BASED MONITORING IN HEMODYNAMIC MONITORING MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND) 211
  • TABLE 106 U.S. HOME-BASED MONITORING IN HEMODYNAMIC MONITORING MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND) 212
  • TABLE 107 U.S. HEMODYNAMIC MONITORING MARKET, BY CONFIGURATION, 2022-2031 (USD THOUSAND) 212
  • TABLE 108 U.S. HEMODYNAMIC MONITORING MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 212
  • TABLE 109 U.S. HEMODYNAMIC MONITORING MARKET, BY END USER, 2022-2031 (USD THOUSAND) 213
  • TABLE 110 U.S. HOSPITALS IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 213
  • TABLE 111 U.S. PRIVATE IN HEMODYNAMIC MONITORING MARKET, BY TIER, 2022-2031 (USD THOUSAND) 213
  • TABLE 112 U.S. PUBLIC IN HEMODYNAMIC MONITORING MARKET, BY TIER, 2022-2031 (USD THOUSAND) 214
  • TABLE 113 U.S. MEDICAL INSTITUTIONS IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 214
  • TABLE 114 U.S. HEMODYNAMIC MONITORING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND) 214
  • TABLE 115 U.S. OFFLINE IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 214
  • TABLE 116 U.S. PHARMACIES IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 215
  • TABLE 117 U.S. ONLINE IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 215
  • TABLE 118 CANADA HEMODYNAMIC MONITORING MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND) 216
  • TABLE 119 CANADA HEMODYNAMIC MONITORING SYSTEMS IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 216
  • TABLE 120 CANADA VITAL SIGN MONITORS IN HEMODYNAMIC MONITORING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 216
  • TABLE 121 CANADA VITAL SIGN MONITORS IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 217
  • TABLE 122 CANADA VITAL SIGN MONITORS IN HEMODYNAMIC MONITORING MARKET, BY CONFIGURATION, 2022-2031 (USD THOUSAND) 217
  • TABLE 123 CANADA VITAL SIGN MONITORS IN HEMODYNAMIC MONITORING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND) 217
  • TABLE 124 CANADA PULSE OXIMETERS IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 217
  • TABLE 125 CANADA PORTABLE PULSE OXIMETERS IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 218
  • TABLE 126 CANADA PULSE OXIMETERS IN HEMODYNAMIC MONITORING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND) 218
  • TABLE 127 CANADA CATHETERS IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 218
  • TABLE 128 CANADA CONSUMABLES AND ACCESSORIES IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 219
  • TABLE 129 CANADA HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 219
  • TABLE 130 CANADA HEMODYNAMIC MONITORING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 219
  • TABLE 131 CANADA HEMODYNAMIC MONITORING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 220
  • TABLE 132 CANADA HOSPITALS-BASED MONITORING IN HEMODYNAMIC MONITORING MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND) 220
  • TABLE 133 CANADA LABORATORY-BASED MONITORING IN HEMODYNAMIC MONITORING MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND) 220
  • TABLE 134 CANADA HOME-BASED MONITORING IN HEMODYNAMIC MONITORING MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND) 221
  • TABLE 135 CANADA HEMODYNAMIC MONITORING MARKET, BY CONFIGURATION, 2022-2031 (USD THOUSAND) 221
  • TABLE 136 CANADA HEMODYNAMIC MONITORING MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 221
  • TABLE 137 CANADA HEMODYNAMIC MONITORING MARKET, BY END USER, 2022-2031 (USD THOUSAND) 222
  • TABLE 138 CANADA HOSPITALS IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 222
  • TABLE 139 CANADA PRIVATE IN HEMODYNAMIC MONITORING MARKET, BY TIER, 2022-2031 (USD THOUSAND) 222
  • TABLE 140 CANADA PUBLIC IN HEMODYNAMIC MONITORING MARKET, BY TIER, 2022-2031 (USD THOUSAND) 223
  • TABLE 141 CANADA MEDICAL INSTITUTIONS IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 223
  • TABLE 142 CANADA HEMODYNAMIC MONITORING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND) 223
  • TABLE 143 CANADA OFFLINE IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 223
  • TABLE 144 CANADA PHARMACIES IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 224
  • TABLE 145 CANADA ONLINE IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 224
  • TABLE 146 MEXICO HEMODYNAMIC MONITORING MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND) 225
  • TABLE 147 MEXICO HEMODYNAMIC MONITORING SYSTEMS IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 225
  • TABLE 148 MEXICO VITAL SIGN MONITORS IN HEMODYNAMIC MONITORING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 225
  • TABLE 149 MEXICO VITAL SIGN MONITORS IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 226
  • TABLE 150 MEXICO VITAL SIGN MONITORS IN HEMODYNAMIC MONITORING MARKET, BY CONFIGURATION, 2022-2031 (USD THOUSAND) 226
  • TABLE 151 MEXICO VITAL SIGN MONITORS IN HEMODYNAMIC MONITORING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND) 226
  • TABLE 152 MEXICO PULSE OXIMETERS IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 226
  • TABLE 153 MEXICO PORTABLE PULSE OXIMETERS IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 227
  • TABLE 154 MEXICO PULSE OXIMETERS IN HEMODYNAMIC MONITORING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND) 227
  • TABLE 155 MEXICO CATHETERS IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 227
  • TABLE 156 MEXICO CONSUMABLES AND ACCESSORIES IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 228
  • TABLE 157 MEXICO HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 228
  • TABLE 158 MEXICO HEMODYNAMIC MONITORING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 228
  • TABLE 159 MEXICO HEMODYNAMIC MONITORING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 229
  • TABLE 160 MEXICO HOSPITALS-BASED MONITORING IN HEMODYNAMIC MONITORING MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND) 229
  • TABLE 161 MEXICO LABORATORY-BASED MONITORING IN HEMODYNAMIC MONITORING MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND) 229
  • TABLE 162 MEXICO HOME-BASED MONITORING IN HEMODYNAMIC MONITORING MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND) 230
  • TABLE 163 MEXICO HEMODYNAMIC MONITORING MARKET, BY CONFIGURATION, 2022-2031 (USD THOUSAND) 230
  • TABLE 164 MEXICO HEMODYNAMIC MONITORING MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 230
  • TABLE 165 MEXICO HEMODYNAMIC MONITORING MARKET, BY END USER, 2022-2031 (USD THOUSAND) 231
  • TABLE 166 MEXICO HOSPITALS IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 231
  • TABLE 167 MEXICO PRIVATE IN HEMODYNAMIC MONITORING MARKET, BY TIER, 2022-2031 (USD THOUSAND) 231
  • TABLE 168 MEXICO PUBLIC IN HEMODYNAMIC MONITORING MARKET, BY TIER, 2022-2031 (USD THOUSAND) 232
  • TABLE 169 MEXICO MEDICAL INSTITUTIONS IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 232
  • TABLE 170 MEXICO HEMODYNAMIC MONITORING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND) 232
  • TABLE 171 MEXICO OFFLINE IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 232
  • TABLE 172 MEXICO PHARMACIES IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 233
  • TABLE 173 MEXICO ONLINE IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 233
  • TABLE 174 EUROPE HEMODYNAMIC MONITORING MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND) 234
  • TABLE 175 EUROPE HEMODYNAMIC MONITORING MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND) 235
  • TABLE 176 EUROPE HEMODYNAMIC MONITORING SYSTEMS IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 235
  • TABLE 177 EUROPE VITAL SIGN MONITORS IN HEMODYNAMIC MONITORING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 235
  • TABLE 178 EUROPE VITAL SIGN MONITORS IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 236
  • TABLE 179 EUROPE VITAL SIGN MONITORS IN HEMODYNAMIC MONITORING MARKET, BY CONFIGURATION, 2022-2031 (USD THOUSAND) 236
  • TABLE 180 EUROPE VITAL SIGN MONITORS IN HEMODYNAMIC MONITORING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND) 236
  • TABLE 181 EUROPE PULSE OXIMETERS IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 236
  • TABLE 182 EUROPE PORTABLE PULSE OXIMETERS IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 237
  • TABLE 183 EUROPE PULSE OXIMETERS IN HEMODYNAMIC MONITORING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND) 237
  • TABLE 184 EUROPE CATHETERS IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 237
  • TABLE 185 EUROPE CONSUMABLES AND ACCESSORIES IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 238
  • TABLE 186 EUROPE HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 238
  • TABLE 187 EUROPE HEMODYNAMIC MONITORING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 238
  • TABLE 188 EUROPE HEMODYNAMIC MONITORING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 239
  • TABLE 189 EUROPE HOSPITALS-BASED MONITORING IN HEMODYNAMIC MONITORING MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND) 239
  • TABLE 190 EUROPE LABORATORY-BASED MONITORING IN HEMODYNAMIC MONITORING MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND) 239
  • TABLE 191 EUROPE HOME-BASED MONITORING IN HEMODYNAMIC MONITORING MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND) 240
  • TABLE 192 EUROPE HEMODYNAMIC MONITORING MARKET, BY CONFIGURATION, 2022-2031 (USD THOUSAND) 240
  • TABLE 193 EUROPE HEMODYNAMIC MONITORING MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 240
  • TABLE 194 EUROPE HEMODYNAMIC MONITORING MARKET, BY END USER, 2022-2031 (USD THOUSAND) 241
  • TABLE 195 EUROPE HOSPITALS IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 241
  • TABLE 196 EUROPE PRIVATE IN HEMODYNAMIC MONITORING MARKET, BY TIER, 2022-2031 (USD THOUSAND) 241
  • TABLE 197 EUROPE PUBLIC IN HEMODYNAMIC MONITORING MARKET, BY TIER, 2022-2031 (USD THOUSAND) 242
  • TABLE 198 EUROPE MEDICAL INSTITUTIONS IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 242
  • TABLE 199 EUROPE HEMODYNAMIC MONITORING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND) 242
  • TABLE 200 EUROPE OFFLINE IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 242
  • TABLE 201 EUROPE PHARMACIES IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 243
  • TABLE 202 EUROPE ONLINE IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 243
  • TABLE 203 GERMANY HEMODYNAMIC MONITORING MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND) 244
  • TABLE 204 GERMANY HEMODYNAMIC MONITORING SYSTEMS IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 244
  • TABLE 205 GERMANY VITAL SIGN MONITORS IN HEMODYNAMIC MONITORING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 244
  • TABLE 206 GERMANY VITAL SIGN MONITORS IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 245
  • TABLE 207 GERMANY VITAL SIGN MONITORS IN HEMODYNAMIC MONITORING MARKET, BY CONFIGURATION, 2022-2031 (USD THOUSAND) 245
  • TABLE 208 GERMANY VITAL SIGN MONITORS IN HEMODYNAMIC MONITORING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND) 245
  • TABLE 209 GERMANY PULSE OXIMETERS IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 245
  • TABLE 210 GERMANY PORTABLE PULSE OXIMETERS IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 246
  • TABLE 211 GERMANY PULSE OXIMETERS IN HEMODYNAMIC MONITORING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND) 246
  • TABLE 212 GERMANY CATHETERS IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 246
  • TABLE 213 GERMANY CONSUMABLES AND ACCESSORIES IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 247
  • TABLE 214 GERMANY HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 247
  • TABLE 215 GERMANY HEMODYNAMIC MONITORING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 247
  • TABLE 216 GERMANY HEMODYNAMIC MONITORING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 248
  • TABLE 217 GERMANY HOSPITALS-BASED MONITORING IN HEMODYNAMIC MONITORING MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND) 248
  • TABLE 218 GERMANY LABORATORY-BASED MONITORING IN HEMODYNAMIC MONITORING MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND) 248
  • TABLE 219 GERMANY HOME-BASED MONITORING IN HEMODYNAMIC MONITORING MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND) 249
  • TABLE 220 GERMANY HEMODYNAMIC MONITORING MARKET, BY CONFIGURATION, 2022-2031 (USD THOUSAND) 249
  • TABLE 221 GERMANY HEMODYNAMIC MONITORING MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 249
  • TABLE 222 GERMANY HEMODYNAMIC MONITORING MARKET, BY END USER, 2022-2031 (USD THOUSAND) 250
  • TABLE 223 GERMANY HOSPITALS IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 250
  • TABLE 224 GERMANY PRIVATE IN HEMODYNAMIC MONITORING MARKET, BY TIER, 2022-2031 (USD THOUSAND) 250
  • TABLE 225 GERMANY PUBLIC IN HEMODYNAMIC MONITORING MARKET, BY TIER, 2022-2031 (USD THOUSAND) 251
  • TABLE 226 GERMANY MEDICAL INSTITUTIONS IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 251
  • TABLE 227 GERMANY HEMODYNAMIC MONITORING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND) 251
  • TABLE 228 GERMANY OFFLINE IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 251
  • TABLE 229 GERMANY PHARMACIES IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 252
  • TABLE 230 GERMANY ONLINE IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 252
  • TABLE 231 FRANCE HEMODYNAMIC MONITORING MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND) 253
  • TABLE 232 FRANCE HEMODYNAMIC MONITORING SYSTEMS IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 253
  • TABLE 233 FRANCE VITAL SIGN MONITORS IN HEMODYNAMIC MONITORING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 253
  • TABLE 234 FRANCE VITAL SIGN MONITORS IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 254
  • TABLE 235 FRANCE VITAL SIGN MONITORS IN HEMODYNAMIC MONITORING MARKET, BY CONFIGURATION, 2022-2031 (USD THOUSAND) 254
  • TABLE 236 FRANCE VITAL SIGN MONITORS IN HEMODYNAMIC MONITORING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND) 254
  • TABLE 237 FRANCE PULSE OXIMETERS IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 254
  • TABLE 238 FRANCE PORTABLE PULSE OXIMETERS IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 255
  • TABLE 239 FRANCE PULSE OXIMETERS IN HEMODYNAMIC MONITORING MARKET, BY TECHNOLOGY, 2022-2031 (USD THOUSAND) 255
  • TABLE 240 FRANCE CATHETERS IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 255
  • TABLE 241 FRANCE CONSUMABLES AND ACCESSORIES IN HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 256
  • TABLE 242 FRANCE HEMODYNAMIC MONITORING MARKET, BY TYPE, 2022-2031 (USD THOUSAND) 256
  • TABLE 243 FRANCE HEMODYNAMIC MONITORING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND) 256
  • TABLE 244 FRANCE HEMODYNAMIC MONITORING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND) 257
  • TABLE 245 FRANCE HOSPITALS-BASED MONITORING IN HEMODYNAMIC MONITORING MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND) 257
  • TABLE 246 FRANCE LABORATORY-BASED MONITORING IN HEMODYNAMIC MONITORING MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND) 257
  • TABLE 247 FRANCE HOME-BASED MONITORING IN HEMODYNAMIC MONITORING MARKET, BY PRODUCT, 2022-2031 (USD THOUSAND) 258
  • TABLE 248 FRANCE HEMODYNAMIC MONITORING MARKET, BY CONFIGURATION, 2022-2031 (USD THOUSAND) 258
  • TABLE 249 FRANCE HEMODYNAMIC MONITORING MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND) 258
  • TABLE 250 FRANCE HEMODYNAMIC MONITORING MARKET, BY END USER, 2022-2031 (USD THOUSAND) 259

LIST OF FIGURES

  • FIGURE 1 GLOBAL HEMODYNAMIC MONITORING MARKET: SEGMENTATION 88
  • FIGURE 2 GLOBAL HEMODYNAMIC MONITORING MARKET: DATA TRIANGULATION 91
  • FIGURE 3 GLOBAL HEMODYNAMIC MONITORING MARKET: DROC ANALYSIS 92
  • FIGURE 4 GLOBAL HEMODYNAMIC MONITORING MARKET : GLOBAL VS REGIONAL MARKET ANALYSIS 93
  • FIGURE 5 GLOBAL HEMODYNAMIC MONITORING MARKET: COMPANY RESEARCH ANALYSIS 93
  • FIGURE 6 GLOBAL HEMODYNAMIC MONITORING MARKET: INTERVIEW DEMOGRAPHICS 95
  • FIGURE 7 GLOBAL HEMODYNAMIC MONITORING MARKET: DBMR MARKET POSITION GRID 96
  • FIGURE 8 GLOBAL HEMODYNAMIC MONITORING MARKET: MARKET APPLICATION COVERAGE GRID 97
  • FIGURE 9 GLOBAL HEMODYNAMIC MONITORING MARKET: VENDOR SHARE ANALYSIS 98
  • FIGURE 10 GLOBAL HEMODYNAMIC MONITORING MARKET: SEGMENTATION 102
  • FIGURE 11 ADVANCEMENTS IN HEMODYNAMIC MONITORING TECHNOLOGIES EXPECTED TO DRIVE THE GLOBAL HEMODYNAMIC MONITORING MARKET GROWTH IN THE FORECAST PERIOD OF 2024 TO 2031 103
  • FIGURE 12 PRODUCT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL HEMODYNAMIC MONITORING MARKET IN THE FORECAST PERIOD OF 2024 & 2031 103
  • FIGURE 13 NORTH AMEIRCA IS EXPECTED TO DOMINATE THE GLOBAL HEMODYNAMIC MONITORING MARKET, AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2024 TO 2031 104
  • FIGURE 14 ASIA-PACIFIC IS THE FASTEST-GROWING MARKET FOR HEMODYNAMIC MONITORING MANUFACTURERS IN THE FORECAST PERIOD OF 2024 TO 2031 105
  • FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE GLOBAL HEMODYNAMIC MONITORING MARKET 114
  • FIGURE 16 GLOBAL HEMODYNAMIC MONITORING MARKET: BY PRODUCT, 2023 126
  • FIGURE 17 GLOBAL HEMODYNAMIC MONITORING MARKET: BY PRODUCT, 2024-2031 (USD THOUSAND) 127
  • FIGURE 18 GLOBAL HEMODYNAMIC MONITORING MARKET: BY PRODUCT, CAGR (2024-2031) 127
  • FIGURE 19 GLOBAL HEMODYNAMIC MONITORING MARKET: BY PRODUCT, LIFELINE CURVE 128
  • FIGURE 20 GLOBAL HEMODYNAMIC MONITORING MARKET: BY TYPE, 2023 141
  • FIGURE 21 GLOBAL HEMODYNAMIC MONITORING MARKET: BY TYPE, 2024-2031 (USD THOUSAND) 142
  • FIGURE 22 GLOBAL HEMODYNAMIC MONITORING MARKET: BY TYPE, CAGR (2024-2031) 142
  • FIGURE 23 GLOBAL HEMODYNAMIC MONITORING MARKET: BY TYPE, LIFELINE CURVE 143
  • FIGURE 24 GLOBAL HEMODYNAMIC MONITORING MARKET: BY MODALITY, 2023 147
  • FIGURE 25 GLOBAL HEMODYNAMIC MONITORING MARKET: BY MODALITY, 2024-2031 (USD THOUSAND) 148
  • FIGURE 26 GLOBAL HEMODYNAMIC MONITORING MARKET: BY MODALITY, CAGR (2024-2031) 148
  • FIGURE 27 GLOBAL HEMODYNAMIC MONITORING MARKET: BY MODALITY, LIFELINE CURVE 149
  • FIGURE 28 GLOBAL HEMODYNAMIC MONITORING MARKET: BY APPLICATION, 2023 154
  • FIGURE 29 GLOBAL HEMODYNAMIC MONITORING MARKET: BY APPLICATION, 2024-2031 (USD THOUSAND) 155
  • FIGURE 30 GLOBAL HEMODYNAMIC MONITORING MARKET: BY APPLICATION, CAGR (2024-2031) 155
  • FIGURE 31 GLOBAL HEMODYNAMIC MONITORING MARKET: BY APPLICATION, LIFELINE CURVE 156
  • FIGURE 32 GLOBAL HEMODYNAMIC MONITORING MARKET: BY CONFIGURATION, 2023 163
  • FIGURE 33 GLOBAL HEMODYNAMIC MONITORING MARKET: BY CONFIGURATION, 2024-2031 (USD THOUSAND) 164
  • FIGURE 34 GLOBAL HEMODYNAMIC MONITORING MARKET: BY CONFIGURATION, CAGR (2024-2031) 164
  • FIGURE 35 GLOBAL HEMODYNAMIC MONITORING MARKET: BY CONFIGURATION, LIFELINE CURVE 165
  • FIGURE 36 GLOBAL HEMODYNAMIC MONITORING MARKET: BY AGE GROUP, 2023 168
  • FIGURE 37 GLOBAL HEMODYNAMIC MONITORING MARKET: BY AGE GROUP, 2024-2031 (USD THOUSAND) 169
  • FIGURE 38 GLOBAL HEMODYNAMIC MONITORING MARKET: BY AGE GROUP, CAGR (2024-2031) 169
  • FIGURE 39 GLOBAL HEMODYNAMIC MONITORING MARKET: BY AGE GROUP, LIFELINE CURVE 170
  • FIGURE 40 GLOBAL HEMODYNAMIC MONITORING MARKET: BY END USER, 2023 174
  • FIGURE 41 GLOBAL HEMODYNAMIC MONITORING MARKET: BY END USER, 2024-2031 (USD THOUSAND) 175
  • FIGURE 42 GLOBAL HEMODYNAMIC MONITORING MARKET: BY END USER, CAGR (2024-2031) 175
  • FIGURE 43 GLOBAL HEMODYNAMIC MONITORING MARKET: BY END USER, LIFELINE CURVE 176
  • FIGURE 44 GLOBAL HEMODYNAMIC MONITORING MARKET: BY DISTRIBUTION CHANNEL, 2023 185
  • FIGURE 45 GLOBAL HEMODYNAMIC MONITORING MARKET: BY DISTRIBUTION CHANNEL, 2024-2031 (USD THOUSAND) 186
  • FIGURE 46 GLOBAL HEMODYNAMIC MONITORING MARKET: BY DISTRIBUTION CHANNEL, CAGR (2024-2031) 186
  • FIGURE 47 GLOBAL HEMODYNAMIC MONITORING MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 187
  • FIGURE 48 GLOBAL HEMODYNAMIC MONITORING MARKET: SNAPSHOT (2023) 194
  • FIGURE 49 GLOBAL HEMODYNAMIC MONITORING MARKET: COMPANY SHARE 2023 (%) 620
  • FIGURE 50 NORTH AMERICA HEMODYNAMIC MONITORING MARKET: COMPANY SHARE 2023 (%) 621
  • FIGURE 51 EUROPE HEMODYNAMIC MONITORING MARKET: COMPANY SHARE 2023 (%) 622
  • FIGURE 52 ASIA-PACIFIC HEMODYNAMIC MONITORING MARKET: COMPANY SHARE 2023 (%) 623